A Nitric Oxide-Releasing Salbutamol Elicits Potent Relaxant and Anti-Inflammatory Activities
Authors:
- Vincent LagenteVLVincent Lagente
- Emmanuel NalineENEmmanuel Naline
- Isabelle GuenonIGIsabelle Guenon
- Marianne CorbelMCMarianne Corbel
- Elisabeth BoichotEBElisabeth Boichot
- Jean-Luc BurgaudJBJean-Luc Burgaud
- Piero Del SoldatoPSPiero Del Soldato
- Charles AdvenierCACharles Advenier
- 1 July 2004
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 310 (1) , 367-375
Abstract
β2-Adrenoceptor agonists are widely used in the treatment of pulmonary diseases. We have investigated the relaxant and anti-inflammatory activities of NCX-950 (α′-[[(1,1-dimethylethy)amino]methyl]-4-hydroxy-1,3-benzenedimethanol nitrate) (a nitric oxide-releasing salbutamol) in human isolated bronchi and on lipopolysaccharide (LPS)-induced acute airway inflammation in mice. NCX-950 (10-8-10-5 M) elicited a relaxation of human isolated bronchi moderately higher than salbutamol, which was reduced by a β-adrenergic blocking drug, propranolol, but not by an inhibitor of guanylate cyclase, ODQ (1H-[1,2,4]oxadiazolo[4,3-] quinolaxin-1-one). The treatment of mice with NCX-950 (1, 10, and 100 μM aerosol) markedly inhibited the neutrophil influx induced by LPS aerosol in bronchoalveolar lavage (BAL) fluid, whereas salbutamol at equimolar doses elicited a moderate inhibition. Pretreatment of mice with NCX-950 (100 μM) also significantly reduced tumor necrosis factor-α, interleukin-6 (IL-6), transforming growth factor-β, and matrix metalloproteinase-9 release in BAL fluid, whereas salbutamol was ineffective. Propranolol, but not ODQ, suppressed the inhibitory activity of NCX-950 on neutrophil influx and IL-6 release in BAL fluids. A nitric oxide-releasing sildenafil NCX-911 [(5-[2-ethoxy-5-(4-methylpiperidinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one nitrate)], but not sildenafil (100 μM) also reduced the neutrophil influx following LPS exposure in mice. This study reported that NCX-950 elicits potent relaxant and anti-inflammatory activities compared with salbutamol, and these effects may be mainly due to the activation of the β2-adrenoceptor rather than the cGMP pathway.Keywords
This publication has 35 references indexed in Scilit:
- Nitric oxide regulates human eosinophil adhesion mechanisms in vitro by changing integrin expression and activity on the eosinophil cell surfaceBritish Journal of Pharmacology, 2001
- Hyperosmolarity reduces the relaxing potency of nitric oxide donors in guinea‐pig tracheaBritish Journal of Pharmacology, 1999
- Mechanisms of relaxations of bovine isolated bronchioles by the nitric oxide donor, GEA 3175British Journal of Pharmacology, 1998
- The relevance of resting tension to responsiveness and inherent tone of human bronchial smooth muscleBritish Journal of Pharmacology, 1998
- Effect of endogenous nitric oxide on tumour necrosis factor-α-induced leukosequestration and IL-8 release in guinea-pigs airwaysin vivoBritish Journal of Pharmacology, 1997
- Nitric oxide and asthmatic inflammationImmunology Today, 1995
- Bronchodilator action of inhaled nitric oxide in guinea pigs.Journal of Clinical Investigation, 1992
- Mechanisms of neutrophil damage to human alveolar extracellular matrix: The role of serine and metalloproteasesJournal of Allergy and Clinical Immunology, 1992
- Salbutamol in the 1980sDrugs, 1989
- Protective effect of drugs on histamine-induced asthma.Thorax, 1977